Cargando…

Autophagy and liver cancer

Autophagy is a highly conserved catabolic process that degrades cytosolic proteins and organelles via formation of autophagosomes that fuse with lysosomes to form autolysosomes, whereby autophagic cargos are degraded. Numerous studies have demonstrated that autophagy plays a critical role in the reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Xiaojuan, Qian, Hui, Wang, Shaogui, Fulte, Sam, Ding, Wen-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641568/
https://www.ncbi.nlm.nih.gov/pubmed/33053934
http://dx.doi.org/10.3350/cmh.2020.0169
_version_ 1783605943509975040
author Chao, Xiaojuan
Qian, Hui
Wang, Shaogui
Fulte, Sam
Ding, Wen-Xing
author_facet Chao, Xiaojuan
Qian, Hui
Wang, Shaogui
Fulte, Sam
Ding, Wen-Xing
author_sort Chao, Xiaojuan
collection PubMed
description Autophagy is a highly conserved catabolic process that degrades cytosolic proteins and organelles via formation of autophagosomes that fuse with lysosomes to form autolysosomes, whereby autophagic cargos are degraded. Numerous studies have demonstrated that autophagy plays a critical role in the regulation of liver physiology and homeostasis, and impaired autophagy leads to the pathogenesis of various liver diseases such as viral hepatitis, alcohol associated liver diseases (AALD), non-alcoholic fatty liver diseases (NAFLD), and liver cancer. Recent evidence indicates that autophagy may play a dual role in liver cancer: inhibiting early tumor initiation while promoting progression and malignancy of already formed liver tumors. In this review, we summarized the progress of current understanding of how hepatic viral infection, alcohol consumption and diet-induced fatty liver diseases impair hepatic autophagy. We also discussed how impaired autophagy promotes liver tumorigenesis, and paradoxically how autophagy is required to promote the malignancy and progression of liver cancer. Understanding the molecular mechanisms underlying how autophagy differentially affects liver cancer development and progression may help to design better therapeutic strategies for prevention and treatment of liver cancer.
format Online
Article
Text
id pubmed-7641568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Association for the Study of the Liver
record_format MEDLINE/PubMed
spelling pubmed-76415682020-11-13 Autophagy and liver cancer Chao, Xiaojuan Qian, Hui Wang, Shaogui Fulte, Sam Ding, Wen-Xing Clin Mol Hepatol Review Autophagy is a highly conserved catabolic process that degrades cytosolic proteins and organelles via formation of autophagosomes that fuse with lysosomes to form autolysosomes, whereby autophagic cargos are degraded. Numerous studies have demonstrated that autophagy plays a critical role in the regulation of liver physiology and homeostasis, and impaired autophagy leads to the pathogenesis of various liver diseases such as viral hepatitis, alcohol associated liver diseases (AALD), non-alcoholic fatty liver diseases (NAFLD), and liver cancer. Recent evidence indicates that autophagy may play a dual role in liver cancer: inhibiting early tumor initiation while promoting progression and malignancy of already formed liver tumors. In this review, we summarized the progress of current understanding of how hepatic viral infection, alcohol consumption and diet-induced fatty liver diseases impair hepatic autophagy. We also discussed how impaired autophagy promotes liver tumorigenesis, and paradoxically how autophagy is required to promote the malignancy and progression of liver cancer. Understanding the molecular mechanisms underlying how autophagy differentially affects liver cancer development and progression may help to design better therapeutic strategies for prevention and treatment of liver cancer. The Korean Association for the Study of the Liver 2020-10 2020-10-01 /pmc/articles/PMC7641568/ /pubmed/33053934 http://dx.doi.org/10.3350/cmh.2020.0169 Text en Copyright © 2020 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Chao, Xiaojuan
Qian, Hui
Wang, Shaogui
Fulte, Sam
Ding, Wen-Xing
Autophagy and liver cancer
title Autophagy and liver cancer
title_full Autophagy and liver cancer
title_fullStr Autophagy and liver cancer
title_full_unstemmed Autophagy and liver cancer
title_short Autophagy and liver cancer
title_sort autophagy and liver cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641568/
https://www.ncbi.nlm.nih.gov/pubmed/33053934
http://dx.doi.org/10.3350/cmh.2020.0169
work_keys_str_mv AT chaoxiaojuan autophagyandlivercancer
AT qianhui autophagyandlivercancer
AT wangshaogui autophagyandlivercancer
AT fultesam autophagyandlivercancer
AT dingwenxing autophagyandlivercancer